The synthetic lethality achieved by combined inhibition of Polθ with other DNA repair proteins, such as PARP1 or RAD52, have an even greater effect on defeating glioblastoma; however, it needs to be studied in the broader context of its toxicity. The gene discussed is RAD52; the disease is glioblastoma.